Bayer Maintains 2026 Outlook on Improved Q2 PerformanceAug 4, 2026Bayer maintained its 2026 outlook after reporting Q2 earnings that exceeded estimates, driven by improved performance while monitoring external market dynamics.Bayer Maintains 2026 Outlook on Improved Q2 PerformancechemweekTopic tracking2026-08-04Bayer Maintains 2026 Outlook on Improved Q2 Performance2026-10-02Bayer to invest $2.2 billion in new US pharma site
ChemBrief